Status:
UNKNOWN
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
Lead Sponsor:
Leeds Cancer Centre at St. James's University Hospital
Conditions:
Melanoma (Skin)
Eligibility:
All Genders
Brief Summary
RATIONALE: Gathering information about vitamin D supplementation and sun exposure in patients with melanoma may help doctors learn more about the disease and find what may affect cancer relapse. PURP...
Detailed Description
OBJECTIVES: * To examine the findings of the pilot study, that vitamin D supplementation in combination with vitamin D receptor (VDR) polymorphisms protects from late relapse (after 3 years) in patie...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosed with melanoma
- Must meet either of the following conditions:
- Resected stage IB, II, or IIIA disease that has relapsed as either stage III or IV disease (cases)
- First loco regional and/or visceral relapse (with/without sentinel node biopsy)
- No more than 3 months since first relapse
- Resected stage IB, II, or IIIA disease that has not relapsed for ≥ 5 years (controls)
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
2774 Patients enrolled
Trial Details
Trial ID
NCT00672321
Start Date
December 1 2007
Last Update
August 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, United Kingdom, LS9 7TF